FTC Asks Novartis To Shed Drug For Alcon Deal
The Federal Trade Commission said Monday that Novartis AG would be required to sell injectable eye drug Miochol-E to Bausch & Lomb Inc. to quell fears that the drugmaker's proposed acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article